vimarsana.com

Page 13 - தேடலை பரிசோதனை இணைக்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer s Beat-And-Raise Quarter, BioLineRx Data

Global Laboratory Information Systems (LIS) Market Expectations & Growth Trends Highlighted until 2028 – KSU

The Global Laboratory Information Systems (LIS) Market report is the best to know the trends and opportunities in industry. The forecast, analysis, evaluations and estimations carried out in this report are all based upon the well established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. These are the authentic tools used in market analysis on which businesses can trust confidently. Research report brings into focus plentiful of factors such as the general market conditions, trends, inclinations, key players, opportunities, and geographical analysis which all aids to take business towards the growth and success. Global Laboratory Information Systems (LIS) Market,

$434 6 Million Worldwide Preimplantation Genetic Testing Industry to 2027 - Impact of COVID-19 on the Market

Share: ResearchAndMarkets.com s offering. Amid the COVID-19 crisis, the global market for Preimplantation Genetic Testing estimated at US$434.6 Million in the year 2020, is projected to reach a revised size of US$775.1 Million by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$408.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.

Quest Diagnostics To Speak At BofA Securities 2021 Virtual Healthcare Conference

Quest Diagnostics To Speak At BofA Securities 2021 Virtual Healthcare Conference News provided by Share this article Share this article SECAUCUS, N.J., April 27, 2021 /PRNewswire/  Quest Diagnostics Incorporated (NYSE: DGX), the world s leading provider of diagnostic information services, announced that it is scheduled to speak at the BofA Securities 2021 Virtual Healthcare Conference.  Mark Guinan, Executive Vice President & CFO will discuss the company s vision, goals, and capital deployment strategies.  The presentation is scheduled for Tuesday, May 11, 2021 at 12:30 p.m. Eastern Time. The presentation will be webcast live during the conference and will be available on the company s investor relations page which can be accessed at ir.QuestDiagnostics.com.  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until June 10, 2021. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.